Search results
Results from the WOW.Com Content Network
Trastuzumab deruxtecan is indicated for the treatment of adults with unresectable (unable to be removed with surgery) or metastatic (when cancer cells spread to other parts of the body) HER2-positive breast cancer who have received two or more prior anti-HER2-based regimens in the metastatic setting and for adults with locally advanced or metastatic HER2-positive gastric or gastroesophageal ...
Trastuzumab is given by slow injection into a vein and injection just under the skin. [31] [34] Common side effects include fever, infection, cough, headache, trouble sleeping, and rash. [31] Other severe side effects include heart failure, allergic reactions, and lung disease. [31] Use during pregnancy may harm the baby. [23]
The safety and effectiveness of trastuzumab emtansine were evaluated in a clinical study of 991 patients randomly assigned to receive trastuzumab emtansine or lapatinib plus capecitabine, another chemotherapy drug. [18] Patients received treatment until either the cancer progressed or the side effects became intolerable. [18]
If you have an inherited intolerance to alcohol, a mutated gene could be the culprit. An at-home DNA test could detect whether you have the mutation, but doctors say there could be some drawbacks.
Other severe side effects include heart failure, allergic reactions, and lung disease. [144] Use during pregnancy may harm the baby. [137] Trastuzumab works by binding to the HER2 receptor and slowing down cell replication. [144] Trastuzumab was approved for medical use in the United States in September 1998, and in the European Union in August ...
The best way to do this is to avoid any alcohol consumption. But if you typically drink while out on dates or just as part of your normal lifestyle, cutting down your intake to one to two small ...
In other words, not only are you more at risk of side effects if you drink a lot of alcohol while you use Viagra — you might also be more at risk of dealing with ED. seb_ra / iStock.
Tucatinib is a kinase inhibitor indicated in combination with trastuzumab and capecitabine for the treatment of adults with advanced unresectable or metastatic HER2-positive breast cancer, including those with brain metastases, who have received one or more prior anti-HER2-based regimens in the metastatic setting.